UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017608
Receipt number R000020410
Scientific Title The safety of liver surgery with No-Drain policy: a multicenter randomized controlled trial
Date of disclosure of the study information 2015/05/18
Last modified on 2017/11/19 13:04:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The safety of liver surgery with No-Drain policy: a multicenter randomized controlled trial

Acronym

No drain policy in liver surgery

Scientific Title

The safety of liver surgery with No-Drain policy: a multicenter randomized controlled trial

Scientific Title:Acronym

No drain policy in liver surgery

Region

Japan


Condition

Condition

Elective hepatic resection without biliary reconstruction

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the safety after hepatic resection using Clavien-Dindo grading system comparing with and without drain

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Frequency of postoperative complication at or greater than Clavien-Dindo grade 3

Key secondary outcomes

Wound-related complication, total postoperative complication, biliary leakage, inflammatory indicator in blood and serum examination, duration of postoperative hospital stay


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Placement of abdominal drain

Interventions/Control_2

Absent of abdominal drain

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Undergoing elective hepatic resection without biliary reconstruction
2) ECOG performance status: 0-2
3) Unimpaired organ function:
1. WBC >= 2,000/mm3
2. Plt >= 50,000/mm3
3. T.Bil <= 2.0 mg/dL
4. Cre <= 1.5 mg/dL
4) Age: 20 years or older
5) Written informed consent

Key exclusion criteria

1) Concomitant resection of other organs excluding gallbladder
2) Administration of anti-coagulant drug just before the operation
3) Schedule to administrate anti-coagulant drug by 3 days after operation
4) Psychiatric disorder
5) Pregnant
6) Supposed extremely high risk of biliary leakage or bleeding after operation because of area of hepatic transection, and exposure of Glisson sheath on transection surface
7) C-tube placement
8) Thoracic tube placement

Target sample size

400


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Junichi Arita

Organization

Graduate School of Medicine, University of Tokyo

Division name

Hepatobiliary-Pancreatic Surgery Division, Department of Surgery

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, 135-8655

TEL

+81-3-3815-5411

Email

jarita-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Junichi Arita

Organization

Graduate School of Medicine, University of Tokyo

Division name

Hepatobiliary-Pancreatic Surgery Division, Department of Surgery

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo, 135-8655

TEL

+81-3-3815-5411

Homepage URL


Email

jarita-tky@umin.ac.jp


Sponsor or person

Institute

Hepatobiliary-Pancreatic Surgery Division, Graduate School of Medicine, University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

P2015004-11Y

Org. issuing International ID_1

Research Ethics Committee, Graduate School of Medicine, University of Tokyo

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 04 Month 30 Day

Date of IRB


Anticipated trial start date

2015 Year 06 Month 05 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 18 Day

Last modified on

2017 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020410


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name